絞り込み

16604

広告

3089件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.

Remote monitoring: Doomed to let down or an attractive promise?

Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.

Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.

[Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: when should treatment be resumed?]

Assessment of potentially inappropriate medications using the EU (7)-PIM list and the Swedish quality indicators.

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement.

An illustrative case of endocardial fibroelastosis and recalcitrant intracardiac thrombosis: a case report.

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies.

Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage.

What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial.

Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban.

Deep vein thrombosis: update on diagnosis and management.

Evaluation of Direct Oral Anticoagulant Dosing and Monitoring in Two Geriatric Outpatient Clinics.

All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.

Stroke in atrial fibrillation: Review of risk stratification and preventive therapy.

The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants:From the Database of a Single-Center Registry.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります